Skip to main content

Advertisement

Log in

Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study is to describe aspects of health-related quality of life (HRQOL) in Mexican patients with antineutrophil cytoplasmic-associated vasculitis (AAV). Cross-sectional comparison study includes patients with established AAV and a comparison group with rheumatoid arthritis (RA), chronic kidney disease (CKD), and healthy subjects. Variables considered were: socio-demographic data, comorbidities, laboratory, disease activity, damage, and Physician’s and Patient’s Global Assessment (PhGA and PtGA). The following measurements were done: Pittsburg sleep quality index, Multidimesional Fatigue Inventory (MFI-20), Hospital Anxiety and Depression Scale, Short Form 36 questionnaire (SF-36), and Health Assessment Questionnaire. 60 patients with AAV were included, median age 54 years, and 60% female. Significant differences were found only in the bodily pain domain of the SF-36 (p = 0.01). Aspects of disease relevant for AAV patients were: fatigue and lack of energy; visual abnormalities; neuropathy; renal impairment; arthritis, and sinusitis. Greater total score on MFI-20 (p < 0.001) and worse PtGA (p = 0.01) were associated with worse physical health. Higher PhGA values were associated with worse physical quality of life (p = 0.01). Greater fatigue score (p = 0.002), greater anxiety-depression score (p = 0.005), and worse PtGA (p = 0.01) were associated with worse mental health quality of life. No differences were found in prevalence of sleep impairment, anxiety, depression, or disability between groups. AAV patients experienced more general and physical fatigue (p < 0.0001), and reduced activity (p = 0.01) than healthy subjects, but similar to RA and CKD patients. Vasculitis has negative effects on patients’ physical and mental HRQOL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Walsh M, Mukhtyar C, Mahr A et al (2011) Health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 63:1055–1061

    Article  Google Scholar 

  2. Basu N, Jones GT, Fluck N et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 49:1383–1390

    Article  PubMed  PubMed Central  Google Scholar 

  3. Merkel PA, Aydin SZ, Boers M et al (2014) Current status of outcome measure development in vasculitis. J Rheumatol 41:593–598

    Article  PubMed  PubMed Central  Google Scholar 

  4. Herlyn K, Hellmich B, Seo P, Merkel PA (2010) Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res (Hoboken) 62:1639–1645

    Article  Google Scholar 

  5. Merkel PA, Aydin SZ, Boers M et al (2011) The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol 38:1480–1486

    Article  PubMed  PubMed Central  Google Scholar 

  6. McClean A, Morgan MD, Basu N et al (2016) Physical fatigue, fitness, and muscle function in patients with antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 68:1332–1339

    Article  CAS  Google Scholar 

  7. Brezinova P, Englbrecht M, Lovric S et al (2013) Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52:1856–1864

    Article  PubMed  Google Scholar 

  8. Carpenter DM, Thorpe CT, Lewis M et al (2009) Health-related quality of life for patients with vasculitis and their spouses. Arthritis Care Res (Hoboken) 61:259–265

    Article  Google Scholar 

  9. Carpenter DM, Meador AE, Elstad EA et al (2012) The impact of vasculitis on patients’ social participation and friendships. Clin Exp Rheumatol 30:S15-S21

    PubMed Central  Google Scholar 

  10. Tomasson G, Boers M, Walsh M et al (2012) Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res (Hoboken) 64:273–279

    Article  Google Scholar 

  11. Trieste L, Palla I, Baldini C et al (2012) Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 30:S154-S156

    Google Scholar 

  12. Instituto Nacional de Estadística y Geografía (INEGI) (2017) Estadísticas a propósito del Día Mundial de la Justicia Social, Boletín Informativo. http://www.inegi.org.mx. Accessed 17 Feb 2017

  13. Flossmann O (2015) Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. Presse Med 44:e251–e257

    Article  PubMed  Google Scholar 

  14. Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11

    Article  CAS  PubMed  Google Scholar 

  15. Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107

    Article  CAS  PubMed  Google Scholar 

  16. Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid Arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581

    Article  PubMed  Google Scholar 

  17. Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61

    Article  PubMed  Google Scholar 

  18. Basu N, McClean A, Harper L et al (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 73:207–211

    Article  PubMed  Google Scholar 

  19. Stone JH, Hoffman GS, Merkel PA et al (2001) A disease specific activity index for Wegener’s granulomatosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912–920

    Article  CAS  PubMed  Google Scholar 

  20. Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371–380

    Article  CAS  PubMed  Google Scholar 

  21. Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213

    Article  CAS  PubMed  Google Scholar 

  22. Mollayeva T, Thurairajah P, Burton K et al (2016) The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev 25:52–73

    Article  PubMed  Google Scholar 

  23. Boada-Grau J, Merino-Tejedor E, Gil-Ripoll C et al (2014) Adaptación al español del Inventario Multidimensional de Fatiga al entorno laboral. Univ Psychol 13:15–23

    Google Scholar 

  24. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52:69–77

    Article  PubMed  Google Scholar 

  25. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370

    Article  CAS  PubMed  Google Scholar 

  26. Ponte C, Sznajd J, O’Neill L, Luqmani R (2014) Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol 32(sup 85):S118–S125

    Google Scholar 

  27. Maruish ME (2011) User’s Manual for the SF-36v2 Health Survey, 3rd edn. QualityMetric Incorporated, Lincoln

    Google Scholar 

  28. Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178

    PubMed  Google Scholar 

  29. González V, Stewart A, Ritter P, Lorig K (1995) Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum 38:1429–1446

    Article  PubMed  Google Scholar 

  30. Zúniga MA, Carrillo-Jiménez GT, Fos PJ et al (1999) Evaluación del estado de salud con la Encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118

    Article  PubMed  Google Scholar 

  31. López-Alvarenga JC, Vázquez-Velázquez V, Arcila-Martínez D (2002) Accuracy and diagnostic utility of the Hospital Anxiety and Depression Scale (HAD) in a sample of obese Mexican patients. Rev Invest Clin 54:403–409

    PubMed  Google Scholar 

  32. Escobar-Córdoba F, Eslava-Schmalbach J (2005) Colombian validation of the Pittsburgh Sleep Quality Index. Rev Neurol 40:150–155

    PubMed  Google Scholar 

  33. Durán-Arenas l, Gallegos-Carrillo K, Salinas-Escudero G et al (2004) Hacia una base normativa Mexicana en la medición de calidad de vida relacionada con la salud, mediante el Formato Corto 36. Salud Publica Mex 46:306–315

    Article  PubMed  Google Scholar 

  34. Acock AC (2012) A Gentle Introduction to Stata, 3rd edn. Stata Press, Texas

    Google Scholar 

  35. Basu N, McClean A, Harper L et al (2013) Explaining fatigue in ANCA-associated vasculitis. Rheumatology 52:1680–1685

    Article  PubMed  Google Scholar 

  36. Basu N, McClean A, Harper L et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology 53:953–956

    Article  CAS  PubMed  Google Scholar 

  37. Novakovich E, Grayson PC (2015) What matters for patients with vasculitis? Presse Med 44:e267–e272

    Article  PubMed  Google Scholar 

  38. Basu N, Murray AD, Jones GT et al (2014) Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology 53:2080–2087

    Article  CAS  PubMed  Google Scholar 

  39. Carpenter DM, Kadis JA, Devellis RF et al (2011) The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission. J Rheumatol 38:709–715

    Article  PubMed  PubMed Central  Google Scholar 

  40. Tomasson G (2013) Quality of life and outcome measures in vasculitis. Best Pract Res Clin Rheumatol 27:69–77

    Article  PubMed  Google Scholar 

  41. van Tuyl LH, Boers M (2012) Patient’s global assessment of disease activity: what are we measuring? Arthritis Rheum 64:2811–2813

    Article  PubMed  Google Scholar 

  42. Jolly M, Kosinski M, Garris CP, Oglesby AK (2016) Prospective validation of the lupus impact tracker: a patient-completed tool for clinical practice to evaluate the impact of systemic lupus erythematosus. Arthritis Rheumatol 68:1422–1431

    Article  PubMed  Google Scholar 

  43. Milman N, Boonen A, Tugwell P, Merkel P (2017) Clinicians’ perspective on key domains in ANCA-associated vasculitis: a Delphi exercise. Scand J Rheumatol 46:112–117

    Article  CAS  PubMed  Google Scholar 

  44. Robson JC, Milman N, Tomasson G et al (2015) Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody–associated vasculitis using the OMERACT process. J Rheumatol 42:2204–2209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Irazú Contreras Yáñez for her valuable help in the scoring and interpretation of the SF-36 and HAQ-DI scales.

Author information

Authors and Affiliations

Authors

Contributions

AHA and NAC designed the study; AHA, AJG, and NAC participated in acquisition of data; AHA, AJG, and NAC analyzed and interpreted data; AHA and NAC drafted the manuscript; AHA, AJG, and NAC revised the manuscript.

Corresponding author

Correspondence to Natasha Alcocer-Castillejos.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Funding

None.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Electronic supplementary material

Below is the link to the electronic supplementary material.

296_2017_3904_MOESM1_ESM.docx

Online 1. STROBE Statement. Online Resource 2. AAV patients with and without sleep disorder. Online Resource 3. AAV patients with and without depression or anxiety (DOCX 145 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hinojosa-Azaola, A., Jiménez-González, A. & Alcocer-Castillejos, N. Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis. Rheumatol Int 38, 631–640 (2018). https://doi.org/10.1007/s00296-017-3904-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3904-1

Keywords

Navigation